AI Precision Oncology Treatment Selection Research

Genomic Biomarker Discovery for Treatment Response Prediction

This research investigates novel somatic and germline genomic alterations that predict differential treatment responses across cancer subtypes. The scientific contribution identifies clinically actionable biomarkers that enable stratification of patients into precision therapy cohorts with higher response rates.

Machine Learning Algorithms for Tumor Molecular Subtyping Integration

This research develops advanced machine learning models that integrate multi-omic data, genomics, transcriptomics, proteomics, and metabolomics, to identify novel tumor subtypes with distinct therapeutic vulnerabilities. The scientific contribution reveals previously unrecognized molecular heterogeneity that reshapes treatment selection paradigms.

Immunotherapy Efficacy Prediction Through Microenvironment Characterization

This research analyzes the tumor immune microenvironment using spatial genomics, single-cell sequencing, and computational modeling to predict immunotherapy response. The scientific contribution establishes quantitative immune signatures that accurately forecast checkpoint inhibitor benefit and resistance mechanisms.

Drug Sensitivity Profiling Using Patient-Derived Tumor Models

This research develops high-throughput functional assays testing patient-derived xenografts and organoids against therapeutic drug panels to identify optimal treatment combinations. The scientific contribution validates in vitro predictions against clinical outcomes and reveals individual drug resistance architectures.

Artificial Neural Networks for Treatment Response Classification Accuracy

This research trains deep learning models on integrated clinical, pathological, and molecular data to classify patients into responder and non-responder categories. The scientific contribution achieves superior predictive accuracy compared to traditional statistical methods and identifies novel decision boundaries.

Synthetic Lethality Discovery and Therapeutic Exploitation in Oncology

This research systematically identifies genetic and pharmacological synthetic lethal interactions specific to individual tumor genetic backgrounds using CRISPR screening and computational prediction. The scientific contribution uncovers targetable vulnerabilities that enable personalized combination therapy selection.

Temporal Dynamics of Tumor Evolution and Treatment Selection Timing

This research models clonal evolution trajectories and temporal genomic changes during tumor progression to optimize treatment initiation and sequencing decisions. The scientific contribution reveals critical therapeutic windows and predicts acquired resistance emergence patterns.

Radiomics and Computer Vision for Imaging-Based Treatment Prediction

This research applies advanced image analysis and radiomics to extract quantitative imaging biomarkers from computed tomography and magnetic resonance imaging scans for treatment outcome prediction. The scientific contribution establishes imaging phenotypes that correlate with underlying molecular subtypes and therapeutic vulnerabilities.

Integration of Circulating Tumor DNA for Real-Time Treatment Monitoring

This research develops machine learning pipelines analyzing circulating tumor DNA sequencing data to monitor treatment response and predict relapse in real time. The scientific contribution enables dynamic treatment adaptation based on molecular response trajectories.

Graph Neural Networks for Drug-Disease Interaction Network Prediction

This research constructs knowledge graphs representing drug mechanisms, gene interactions, and disease pathways, then applies graph neural networks to predict optimal therapy nodes. The scientific contribution identifies emergent properties of drug combinations by learning from network topology.